HiRO supports a broad range of radiopharmaceutical programs across therapeutic, diagnostic, and theranostic applications. Our teams are experienced in isotope-specific operational planning, nuclear medicine workflows, and complex global studies requiring disciplined execution and regulatory alignment.

Radiopharmaceutical studies require a partner who can bring structure to complexity and clarity to every decision. As isotope logistics intensify, timelines tighten, and regulatory requirements evolve, sponsors need guidance that is both disciplined and steady. HiRO brings biometrics rigor, transparent communication, and thoughtful operational oversight together—helping teams move through each stage with confidence.

By combining global operational strength with radiopharmaceutical expertise, we ensure every program benefits from unified standards and deeply connected teams. Through our HiRO Linkage™ Approach, radiopharmaceutical studies advance with aligned expectations, consistent communication, and the collective wisdom of shared global experience.

We don’t just manage timelines—we help radiopharmaceutical sponsors navigate the full regulatory journey with confidence. From early strategy through global submissions and beyond, HiRO supports radiopharmaceutical programs with regulatory-aligned planning and globally informed execution.

Proactive Planning
Anticipating isotope logistics, site readiness, and radiation safety challenges before they become delays.

Integrated Approach
Aligning clinical, scientific, regulatory, and operational strategies.

Global Perspective
Supporting multi-regional radiopharmaceutical programs and evolving nuclear medicine regulations.

Collaborative Partnership
Working side-by-side to ensure clarity, compliance, and operational confidence.

Our goal is simple: help radiopharmaceutical programs move from concept to clinic efficiently—without compromising safety, precision, or regulatory confidence.